MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 15, 2005; DOI: 10.1124/mol.105.015982


0026-895X/05/6805-1291-1300$20.00
Mol Pharmacol 68:1291-1300, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.015982v1
68/5/1291    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ernst, M.
Right arrow Articles by Sieghart, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ernst, M.
Right arrow Articles by Sieghart, W.

Comparative Models of GABAA Receptor Extracellular and Transmembrane Domains: Important Insights in Pharmacology and Function

Margot Ernst, Stefan Bruckner, Stefan Boresch, and Werner Sieghart

Center for Brain Research, Division of Biochemistry and Molecular Biology, Medical University of Vienna, Vienna, Austria (M.E., S.Br., W.S.); and Department of Biomolecular and Structural Chemistry, University of Vienna, Vienna, Austria (S.Bo.)

Comparative models of the extracellular and transmembrane domains of GABAA receptors in the agonist-free state were generated based on the recently published structures of the nicotinic acetylcholine receptor. The models were validated by computational methods, and their reliability was estimated by analyzing conserved and variable elements of the cys-loop receptor topology. In addition, the methodological limits in the interpretation of such anion channel receptor models are discussed. Alignment ambiguities in the helical domain were resolved for helix 3 by placing two gaps into the linker connecting helices 2 and 3. The resulting models were shown to be consistent with a wide range of pharmacological and mutagenesis data from GABAA and glycine receptors. The loose packing of the models results in a large amount of solvent-accessible space and offers a natural explanation for the rich pharmacology and the great flexibility of these receptors that are known to exist in numerous drug-induced conformational states. Putative drug binding pockets found within and between subunits are described, and amino acid residues important for the action and subtype selectivity of volatile and intravenous anesthetics, barbiturates, and furosemide are shown to be part of these pockets. The entire helical domain, however, seems to be crucial not only for binding of drugs but also for transduction of binding to gating or of allosteric modulation. These models can now be used to design new experiments for clarification of pharmacological and structural questions as well as for investigating and visualizing drug induced conformational changes.


Received June 26, 2005; accepted August 15, 2005

Address correspondence to: Univ. Prof. Dr. Werner Sieghart, Center for Brain Research, Medical University Vienna, Division of Biochemistry and Molecular Biology, Spitalgasse 4, A-1090 Vienna, Austria. E-mail: werner.sieghart{at}meduniwien.ac.at




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Nirthanan, G. Garcia III, D. C. Chiara, S. S. Husain, and J. B. Cohen
Identification of Binding Sites in the Nicotinic Acetylcholine Receptor for TDBzl-etomidate, a Photoreactive Positive Allosteric Effector
J. Biol. Chem., August 8, 2008; 283(32): 22051 - 22062.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Y. Rula, A. H. Lagrange, M. M. Jacobs, N. Hu, R. L. Macdonald, and R. B. Emeson
Developmental Modulation of GABAA Receptor Function by RNA Editing
J. Neurosci., June 11, 2008; 28(24): 6196 - 6201.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. P. Barrera, J. Betts, H. You, R. M. Henderson, I. L. Martin, S. M. J. Dunn, and J. M. Edwardson
Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the {alpha}4{beta}3{delta} GABAA Receptor
Mol. Pharmacol., March 1, 2008; 73(3): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Sarto-Jackson, R. Furtmueller, M. Ernst, S. Huck, and W. Sieghart
Spontaneous Cross-link of Mutated {alpha}1 Subunits during GABAA Receptor Assembly
J. Biol. Chem., February 16, 2007; 282(7): 4354 - 4363.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G.-D. Li, D. C. Chiara, G. W. Sawyer, S. S. Husain, R. W. Olsen, and J. B. Cohen
Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog.
J. Neurosci., November 8, 2006; 26(45): 11599 - 11605.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. C. Drafts and J. L. Fisher
Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Jansen and M. H. Akabas
State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments.
J. Neurosci., April 26, 2006; 26(17): 4492 - 4499.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics